Compare ESQ & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESQ | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 783.2M |
| IPO Year | 2017 | 2016 |
| Metric | ESQ | BVS |
|---|---|---|
| Price | $122.14 | $11.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $120.33 | $14.00 |
| AVG Volume (30 Days) | 136.3K | ★ 706.8K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | 14.20 | ★ 163.46 |
| EPS | ★ 1.40 | 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $35.15 | $7.52 |
| Revenue Next Year | $39.09 | $7.06 |
| P/E Ratio | ★ $82.87 | $287.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $90.57 | $5.81 |
| 52 Week High | $125.85 | $12.53 |
| Indicator | ESQ | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 58.18 |
| Support Level | $103.79 | $8.04 |
| Resistance Level | $125.40 | $12.53 |
| Average True Range (ATR) | 3.42 | 0.54 |
| MACD | -0.36 | -0.07 |
| Stochastic Oscillator | 69.41 | 41.30 |
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.